Goodwin

James Oh

Deals
3
Latest
May 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 3 deals
Deals by year
James Oh: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals James Oh was named on, most recent first
May 2026 Perfuse Therapeutics –BayerAcquisitionLegal adviser to Perfuse Therapeutics (target)Announced300.0Biotech+2Bayer acquisition of Perfuse Therapeutics
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionLegal adviser to Orna Therapeutics (target)Announced2,400.0Biotech+1Eli Lilly and Company acquisition of Orna Therapeutics
Jan 2026 XConn –MarvellAcquisitionLegal adviser to XConn Technologies (target)Completed540.0Hardware & SemiconductorsMarvell acquisition of XConn

Deals where James Oh is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.